Summary
The salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel have been compared. The bioadhesive tablet consisted of a mixture of thermally modified starch and 5% polyacrylic acid.
Although the amount of drug administered via the bioadhesive tablet was sixfold lower than when the gel was used, the salivary miconazole levels were higher and remained above the MIC value ofCandida albicans for more than 10 hours. The mean adhesion time of the tablet was 586 min.
The bioadhesive tablet appears to be a promising drug delivery system for the buccal administration of drugs for local therapy.
Similar content being viewed by others
References
Bottenberg P, Cleymaet R, De Muynck C, Remon J-P, Coomans D, Michotte Y, Slop D (1991) Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol 43: 457–464
Casneuf J, de Loore F, Dhondt F, Devlieger H, Poot J, van den Bon P, van Eygen M (1980) Oral thrush in children treated with miconazole gel. Mykosen 23: 75–78
Chen JL, Cyr GN (1970) Compositions producing adhesion through hydration In: Marly RS (ed) Adhesion in biological systems. Academic Press, New York London, pp 163–181
Davis SS, Kennerley JW, Taylor MJ, Gardy JG, Wilson CG (1983) Design and evaluation of sustained release formulations for oral and buccal administration. Adv Pharmacother 1: 17–25
Deasy PB, O'Neill CT (1989) Bioadhesive dosage form for peroral administration of timolol base. Pharm Acta Helv 64: 231–235
Ekstrand J, Spak C-J, Vogel G (1990) Pharmacokinetics of fluoride in man and its clinical relevance. J Dent Res 69 (Spec Issue): 550–555
Gurny R, Meyer JM, Peppas NA (1984) Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials 5: 336–340
Hardy JG, Kennerley JW, Wilson CG, Davis SS (1982) Release rates from sustained release buccal tablets in man. J Pharm Pharmacol 34: 91P
Holt RJ (1980) The Imidazoles. In: Speller DCE (ed) Antifungal Chemotherapy. Wiley, London, pp 107
Odds FC (1981) Persistence of miconazole in saliva after a single oral dose. Clin Res Rev 1: 231–232
Pederson M, Rassing MR (1990) Miconazole chewing gum as a drug delivery system application of a solid dispersion technique and lecithin. Drug Dev Ind Pharm 16: 2015–2030
Ponchel G, Touchard F, Duchêne D, Peppas NA (1987) Bioadhesive analysis of controlled-release systems: I. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems. J Contr Rel 5: 129–141
Reading JH, Clifford PD, Coles RW, Rajagopalan N (1981) An open assessment of miconazole oral gel in the treatment of paediatric oral candidosis in general practice. Curr Ther Res 30: 605–610
Shumaker RL, Boxenbaum H, Thompson GA (1988) ABSPLOTS: A lotus 123 spreadsheet for calculating and plotting drug absorption rates. Pharm Res 5: 247–248
Siegel S, Castellan N (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York Singapore
Tucker IG, Szylkarski HAM, Romaniuk K (1989) The behaviour of bioadhesive betamethasone tablets in the mouth. J Clin Pharm Ther 14: 153–158
Turner A, Warnock DW (1982) Determination of miconazole in human saliva using high-performance liquid chromatography. J Chrom 227: 229–232
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bouckaert, S., Schautteet, H., Lefebvre, R.A. et al. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Pharmacol 43, 137–140 (1992). https://doi.org/10.1007/BF01740659
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01740659